Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 6 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

25%

1 of 4 completed trials have results

Key Signals

1 recruiting1 with results

Enrollment Performance

Analytics

No phase data available

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (6)

Showing 6 of 6 trials
NCT04794868Completed

PreDiction and Validation of Clinical CoursE of Coronary Artery DiSease With CT-Derived Non-Invasive HemodYnamic Phenotyping and Plaque Characterization (DESTINY Study)

Role: collaborator

NCT06018194Recruiting

ELUCIDATE FFRct Study

Role: lead

NCT04439643Completed

Plaque Stratification Using Ccta in Coronary ARtery Disease (PoSTCARD)

Role: lead

NCT05524896Completed

Elucidate Vasodilatory Capacity From Histology-Defined Analysis of Coronary CT Angiography

Role: lead

NCT04448353Unknown

Carotid Risk Prediction (CRISP) Consortium

Role: lead

NCT02143102Completed

Non-invasive Computer-Aided Phenotyping of Vasculopathy

Role: lead

All 6 trials loaded